Profile
| Metric | Value |
|---|---|
| Full Name | Collegium Pharmaceutical, Inc. |
| Ticker | NASDAQ: COLL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | collegiumpharma.com |
| Employees | 357 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $47.01 | |
| Price, 1D Change | -1.45% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | 29.26 | |
| Beta | 0.47 | |
| Revenue | $631M | |
| Revenue, 1Y Change | +11.41% | |
| EPS | $1.86 | |
| EPS, 1Y Change | +43.56% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $1.86 | |
| EPS Estimate | $7.47 | |
| EPS Est. Change | +302.27% | |
| Revenue | $631.45M | |
| Revenue Estimate | $781.29M | |
| Revenue Est. Change | +23.73% | |
| Current Price | $47.01 | |
| Price Target | - | $55.50 |
| Price Tgt. Change | - | +18.06% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.08 | $1.29 | +19.75% | |
| $6.18 | $1.86 | -69.96% | |
| $7.47 | N/A | +302.27% | |
| $7.94 | N/A | +327.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $564.84M | $566.77M | +0.34% | |
| $629.18M | $631.45M | +0.36% | |
| $781.29M | N/A | +23.73% | |
| $808.06M | N/A | +27.97% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +44.42% | |
| Price, 3Y | +70.51% | |
| Market Cap, 1Y | +45.21% | |
| Market Cap, 3Y | +59.24% | |
| Revenue, 1Y | +11.41% | |
| Revenue, 3Y | +128.07% | |
| EPS, 1Y | +43.56% | |
| EPS, 3Y | +0.02% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $47.01 | |
| SMA 200 | $35.95 | |
| SMA 200 vs Price | -23.52% | |
| SMA 50 | $47.00 | |
| SMA 50 vs Price | -0.02% | |
| Beta | 0.47 | |
| ATR | $1.83 | |
| 14-Day RSI | 50.12 | |
| 10-Day Volatility | 60.09% | |
| 1-Year Volatility | 38.22% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $631.45M | |
| EPS | $1.86 | |
| Gross Profit | $377.34M | |
| Gross Margin | 59.76% | |
| Operating Profit | $166.98M | |
| Operating Margin | 30.30% | |
| Net Income | $69.19M | |
| Net Margin | 10.96% | |
| EBITDA | $341.70M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 4.28 | |
| Current Ratio | 0.95 | |
| Quick Ratio | 0.88 | |
| Interest Coverage | - | |
| F-Score | 8 | |
| Altman Z-Score | 1.19 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 29.26 | |
| PS Ratio | 1.96 | |
| PB Ratio | 5.41 | |
| EV/EBITDA | 5.45 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $228.84M | |
| Cash & Equivalents | $70.57M | |
| Total Assets | $1.66B | |
| Current Assets | $482.26M | |
| Total Liabilities | $1.43B | |
| Current Liabilities | $509.51M | |
| Total Debt | $979.91M | |
| Short Term Debt | $65.85M | |
| Accounts Payable | $3.93M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $464.47M | |
| Operating Expenses | $210.36M | |
| Cost Of Goods Sold | $254.11M | |
| SG&A | $210.36M | |
| D&A | $169.16M | |
| Interest Expense | $0.00 | |
| Income Tax | $29.38M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $204.98M | |
| CFI | -$287.76M | |
| CFF | -$60.60M | |
| Capex | $1.65M | |
| Free Cash Flow | $203.33M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Barclays | → | |
| Needham | → | |
| Barclays | ||
| Truist Securities | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Piper Sandler | → | |
| Needham | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with COLL
FAQ
What is the ticker symbol for Collegium Pharmaceutical, Inc.?
The ticker symbol for Collegium Pharmaceutical, Inc. is NASDAQ:COLL
Does Collegium Pharmaceutical, Inc. pay dividends?
No, Collegium Pharmaceutical, Inc. does not pay dividends
What sector is Collegium Pharmaceutical, Inc. in?
Collegium Pharmaceutical, Inc. is in the Healthcare sector
What industry is Collegium Pharmaceutical, Inc. in?
Collegium Pharmaceutical, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Collegium Pharmaceutical, Inc. based in?
Collegium Pharmaceutical, Inc. is headquartered in United States
When did Collegium Pharmaceutical, Inc. go public?
Collegium Pharmaceutical, Inc. initial public offering (IPO) was on May 7, 2015
Is Collegium Pharmaceutical, Inc. in the S&P 500?
No, Collegium Pharmaceutical, Inc. is not included in the S&P 500 index
Is Collegium Pharmaceutical, Inc. in the NASDAQ 100?
No, Collegium Pharmaceutical, Inc. is not included in the NASDAQ 100 index
Is Collegium Pharmaceutical, Inc. in the Dow Jones?
No, Collegium Pharmaceutical, Inc. is not included in the Dow Jones index
When was Collegium Pharmaceutical, Inc. last earnings report?
Collegium Pharmaceutical, Inc.'s most recent earnings report was on November 6, 2025
When does Collegium Pharmaceutical, Inc. report earnings?
The next expected earnings date for Collegium Pharmaceutical, Inc. is February 26, 2026
Data Sources & References
- COLL Official Website www.collegiumpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1267565/000110465925107391/0001104659-25-107391-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1267565/000155837025001801/0001558370-25-001801-index.htm
- COLL Profile on Yahoo Finance finance.yahoo.com/quote/COLL
- COLL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coll
